Hints and tips:
Related Special Reports
...The judgment forced Scholz and his ministers to make huge savings in their 2024 budget, a revised version of which only passed on Friday last week....
...among the top five destinations for deploying capital this year, according to the 2024 survey of more than 60 investors including hotel owners, developers and private funds, which will be announced this week...
...Two weeks ago, shares in Merck’s rival Bayer dropped to their lowest level in a decade after the company abandoned a late-stage trial of a blood-thinning drug....
...Merck Mercuriadis, adviser to Hipgnosis Songs Fund, has offered to drop a controversial clause giving him the right to buy the group’s music portfolio as he battles to stay on at the investment trust he...
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...The Swiss company already has a packed pipeline. The problem is that too many drug trials have failed. Merck knows how that feels....
...A few weeks ago, a friend was about to have life-saving brain surgery in Boston when her operation was suddenly cancelled. The reason?...
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
...New data from Moderna and Merck this week offered a promising update on this front....
...But, of course, there’s a reason why it’s widely called Shitibank; the sprawling, gormless Citi has for a v v v very long time proven adept at blithely ambling onto various rakes around the world....
...In the weeks after the deal was revealed, Samsung, TSMC and JSR’s other big customers sought an explanation for why a listed company that was not financially struggling was hurriedly being taken private...
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...A fondness for European defence stocks has been a somewhat oddball hobby for most of the last decade or two, but like V-neck jumpers, the sector is firmly back in fashion....
...Barclays finds that in the week of earnings or a deliveries update, the stock is down 7 per cent on average....
...Delta Air Lines last week raised the price of checking in a first bag from $30 to $35....
...Buidl’s yield and BlackRock’s backing make it far higher quality collateral than a stablecoin issued by an unregulated far-off company....
...Merck’s lawsuit is the first by a major drug company, but analysts predict others are likely to follow its lead and sue the government ahead of the full implementation of the drug price negotiation elements...
...A popular one is that traders expected the BoJ to sound more hawkish last week, were disappointed and started selling yen....
...The FT last week reported that Tesla was scouting locations in India for a new EV plant in which it would invest $2bn-$3bn. The company has been through previous rounds of job cuts....
...Athleisure retailer Lululemon and sneaker maker Nike, reporting last week, both fell short of the mark....
...A landmark class action settlement this week wants to change that....
...Last week, Dollar Tree announced plans to close down nearly 1,000 — or 12 per cent of — Family Dollar stores....
...MSD, known as Merck in the US, expects competition for its Keytruda cancer treatment from late 2028. Sales of Eliquis, a small molecule pill, are expected to top $13bn in 2025....
...Tim Cook, Apple’s chief executive, is visiting Vietnam this week as the iPhone maker plans to increase its supply chain there....
...Yet Merck recorded sales worth more than $6bn between 2021 and 2022, and the figure does not include sales in poorer markets where licensed companies make generic versions of the drug....
International Edition